HAVCR2 and myelodysplastic syndrome: Tao et al. found that HSCs in myelodysplastic syndromes exhibited high TIM-3 expression, and TIM-3+ HSCs exhibited abnormal differentiation, excessive proliferation, and reduced apoptosis [24].